Love Pharma Inc (TSE:JOLT)
CNQX:JOLT

Love Pharma Inc (JOLT) Financial Statements

3 Followers

Love Pharma Inc Financial Overview

Love Pharma Inc's market cap is currently ―. The company's EPS TTM is C$-0.009; its P/E ratio is -1.02; Love Pharma Inc is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -212.25KC$ -297.83KC$ -28.37KC$ -143.97KC$ -278.35K
EBITDAC$ -212.25KC$ -297.83KC$ -28.37KC$ -143.97KC$ -278.35K
Net Income Common StockholdersC$ -212.25KC$ -297.83KC$ -28.37KC$ -151.39KC$ -288.15K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 273.79KC$ 2.06KC$ 1.61KC$ 37.30KC$ 3.63K
Total AssetsC$ 667.36KC$ 372.43KC$ 736.92KC$ 750.11KC$ 752.76K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 155.07K
Net DebtC$ -273.79KC$ -2.06KC$ -1.61KC$ -37.30KC$ 151.44K
Total LiabilitiesC$ 522.03KC$ 499.34KC$ 421.91KC$ 453.39KC$ 662.11K
Stockholders EquityC$ 145.33KC$ -126.92KC$ 315.01KC$ 296.72KC$ 90.65K
Cash Flow-
Free Cash FlowC$ -37.98KC$ 16.55KC$ -82.34KC$ -18.30KC$ -37.98K
Operating Cash FlowC$ -37.98KC$ 16.55KC$ -82.34KC$ -18.30KC$ -37.98K
Investing Cash Flow-----
Financing Cash FlowC$ 484.50KC$ -16.10KC$ 46.66KC$ 51.97K-
Currency in CAD

Love Pharma Inc Earnings and Revenue History

Love Pharma Inc Debt to Assets

Love Pharma Inc Cash Flow

Love Pharma Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis